CStone Pharmaceuticals (HKG:2616)
Hong Kong
· Delayed Price · Currency is HKD 4.450
+0.160 (3.73%)
Jun 25, 2025, 4:08 PM HKT
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 6.04 billion as of June 25, 2025. Its market cap has increased by 304.72% in one year.
Market Cap
6.04B
Enterprise Value
5.65B
Revenue
433.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.45
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 12.65B to 6.04B, a decrease of -52.28%. That is a compound annual growth rate of -11.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 230.13B |
| Hansoh Pharmaceutical Group Company | 170.05B |
| Innovent Biologics | 130.31B |
| JD Health International | 127.04B |
| WuXi Biologics | 98.06B |
| Sino Biopharmaceutical | 92.28B |
| CSPC Pharmaceutical Group | 88.12B |
| Akeso | 85.45B |